LogicBio Therapeutics

Fred Chereau, CEO

April 20 | 3:00pm | Gaudi 2 Ballroom

Lexington, MA

(NASDAQ: LOGC)

In-Person Presentation

LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering genome editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood. The company’s genome editing platform, GeneRide™, is a new approach to precise gene insertion harnessing a cell’s natural DNA repair process potentially leading to durable therapeutic protein expression levels. The company’s gene delivery platform, sAAVy™, is an adeno-associated virus capsid engineering platform designed to optimize gene delivery for treatments in a broad range of indications and tissues.

www.logicbio.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions